Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Receivables (2016 - 2025)

Historic Receivables for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $215.9 million.

  • Phibro Animal Health's Receivables rose 1255.7% to $215.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $215.9 million, marking a year-over-year increase of 1255.7%. This contributed to the annual value of $228.0 million for FY2025, which is 3339.13% up from last year.
  • Latest data reveals that Phibro Animal Health reported Receivables of $215.9 million as of Q4 2025, which was up 1255.7% from $217.9 million recorded in Q3 2025.
  • Phibro Animal Health's Receivables' 5-year high stood at $228.0 million during Q2 2025, with a 5-year trough of $135.6 million in Q1 2021.
  • For the 5-year period, Phibro Animal Health's Receivables averaged around $167.6 million, with its median value being $158.7 million (2022).
  • Per our database at Business Quant, Phibro Animal Health's Receivables plummeted by 1055.32% in 2021 and then skyrocketed by 3552.68% in 2025.
  • Over the past 5 years, Phibro Animal Health's Receivables (Quarter) stood at $142.5 million in 2021, then grew by 6.55% to $151.8 million in 2022, then decreased by 0.79% to $150.6 million in 2023, then grew by 27.33% to $191.8 million in 2024, then rose by 12.56% to $215.9 million in 2025.
  • Its Receivables stands at $215.9 million for Q4 2025, versus $217.9 million for Q3 2025 and $228.0 million for Q2 2025.